Fabiana Perna

11PUBLICATIONS
82CO-AUTHORS
Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jul 21, 2026
Chronic graft vs. host disease following post-transplant cyclophosphamide (PTCy) based prophylaxis vs. non-PTCy prophylaxis.

|Jun 20, 2026
Expanded antigen-specific donor regulatory T cells for GVHD prevention.

|Jun 11, 2026
Product-intrinsic NF-κB-driven transcriptional programs connote durability of CAR-T response in multiple myeloma.

|Apr 16, 2025
Sarcopenia and Skeletal Muscle Loss after CAR T-cell Therapy in Diffuse Large B-cell Lymphoma.

Khushali Jhaveri, Ram Thapa, Dalia Ercan

|Jun 11, 2024
CAR T-cell toxicities: from bedside to bench, how novel toxicities inform laboratory investigations.

Fabiana Perna, Samir Parekh, Caroline Diorio

|Mar 16, 2024
Translation efficiency driven by CNOT3 subunit of the CCR4-NOT complex promotes leukemogenesis.

Maryam Ghashghaei, Yilin Liu, James Ettles

Pageof 2

Frequent Collaborators

5 joint publications

Taiga Nishihori

4 joint publications

Omar Alexis Castaneda-Puglianini

4 joint publications

Hien D Liu

3 joint publications

Ciara L Freeman